RS51306B - Postupak i intermedijerna jedinjenja korisna za dobijanje statina, naročito rosuvastatina - Google Patents
Postupak i intermedijerna jedinjenja korisna za dobijanje statina, naročito rosuvastatinaInfo
- Publication number
- RS51306B RS51306B RSP20100217A RS51306B RS 51306 B RS51306 B RS 51306B RS P20100217 A RSP20100217 A RS P20100217A RS 51306 B RS51306 B RS 51306B
- Authority
- RS
- Serbia
- Prior art keywords
- formula
- compound
- group
- protecting
- protecting group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0406757A GB0406757D0 (en) | 2004-03-26 | 2004-03-26 | Process and compounds |
| PCT/GB2005/001099 WO2005092867A2 (en) | 2004-03-26 | 2005-03-23 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS51306B true RS51306B (sr) | 2010-12-31 |
Family
ID=32188702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RSP20100217 RS51306B (sr) | 2004-03-26 | 2005-03-23 | Postupak i intermedijerna jedinjenja korisna za dobijanje statina, naročito rosuvastatina |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8703945B2 (sr) |
| EP (2) | EP1958633B1 (sr) |
| JP (1) | JP5016478B2 (sr) |
| KR (1) | KR20060130765A (sr) |
| CN (1) | CN101022807B (sr) |
| AT (2) | ATE536875T1 (sr) |
| AU (1) | AU2005225602A1 (sr) |
| BR (1) | BRPI0507999A (sr) |
| CA (1) | CA2561059C (sr) |
| CY (2) | CY1110091T1 (sr) |
| DE (1) | DE602005019547D1 (sr) |
| DK (2) | DK1729775T3 (sr) |
| ES (2) | ES2341658T3 (sr) |
| GB (1) | GB0406757D0 (sr) |
| HR (1) | HRP20100287T1 (sr) |
| IL (1) | IL178274A0 (sr) |
| PL (2) | PL1958633T3 (sr) |
| PT (2) | PT1958633E (sr) |
| RS (1) | RS51306B (sr) |
| SI (2) | SI1729775T1 (sr) |
| WO (1) | WO2005092867A2 (sr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4359141B2 (ja) | 2001-07-13 | 2009-11-04 | アストラゼネカ・ユーケイ・リミテッド | アミノピリミジン化合物の製造 |
| GB0218781D0 (en) | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
| GB0312896D0 (en) | 2003-06-05 | 2003-07-09 | Astrazeneca Ab | Chemical process |
| GB0324791D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
| GB0406757D0 (en) * | 2004-03-26 | 2004-04-28 | Avecia Ltd | Process and compounds |
| GB0427491D0 (en) | 2004-12-16 | 2005-01-19 | Avecia Ltd | Process and compounds |
| CA2612587C (en) | 2005-06-24 | 2013-02-19 | Lek Pharmaceuticals D.D. | Process for preparing amorphous rosuvastatin calcium free of impurities |
| WO2008119810A2 (en) * | 2007-04-03 | 2008-10-09 | Lek Pharmaceuticals D.D. | Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof |
| EP1978020A1 (en) * | 2007-04-03 | 2008-10-08 | LEK Pharmaceuticals D.D. | Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof |
| WO2009092702A2 (en) | 2008-01-23 | 2009-07-30 | Lek Pharmaceuticals D.D. | ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof |
| AU2013202895B2 (en) * | 2009-03-10 | 2014-09-18 | Redx Pharma Plc | Rosuvastatin and atorvastatin derivatives |
| GB0904100D0 (en) * | 2009-03-10 | 2009-04-22 | Bradford Pharma Ltd | Use of rosuvastatin lactols as medicaments |
| GB0904104D0 (en) * | 2009-03-10 | 2009-04-22 | Bradford Pharma Ltd | Atorvastatin and rosuvastatin derivatives |
| GB0904102D0 (en) * | 2009-03-10 | 2009-04-22 | Bradford Pharma Ltd | Use of atorvastatin lactols as medicaments |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474971A (en) * | 1982-09-29 | 1984-10-02 | Sandoz, Inc. | (Tetrahydropyran-2-yl)-aldehydes |
| US4625039A (en) * | 1983-12-21 | 1986-11-25 | Sandoz Pharm. Corp. | 4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediates |
| US4677211A (en) * | 1984-06-29 | 1987-06-30 | Sandoz Pharmaceuticals Corp. | Preparation of lactones |
| JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US5795749A (en) | 1995-04-05 | 1998-08-18 | The Scripps Research Institution | Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives |
| GB9903472D0 (en) | 1999-02-17 | 1999-04-07 | Zeneca Ltd | Chemical process |
| WO2001022962A1 (en) * | 1999-09-30 | 2001-04-05 | Merck & Co., Inc. | Anti-hypercholesterolemic drug combination |
| GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
| GB0011163D0 (en) * | 2000-05-10 | 2000-06-28 | Astrazeneca Ab | Chemical compound |
| EP1465667A4 (en) * | 2001-09-24 | 2007-06-27 | Merck & Co Inc | SCREENING AND SELECTION PROCEDURE FOR STATIN COMBINATIONS |
| DE10216967A1 (de) * | 2002-04-16 | 2003-11-13 | Bayer Ag | Verfahren zur Herstellung spezieller aromatischer Aldehyde |
| US7371759B2 (en) * | 2003-09-25 | 2008-05-13 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
| CN1886383A (zh) | 2003-10-22 | 2006-12-27 | 兰贝克赛实验室有限公司 | 无定形罗苏伐他汀钙的制备方法 |
| DE10352659B4 (de) | 2003-11-11 | 2007-09-13 | Ratiopharm Gmbh | Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren |
| GB0406757D0 (en) * | 2004-03-26 | 2004-04-28 | Avecia Ltd | Process and compounds |
-
2004
- 2004-03-26 GB GB0406757A patent/GB0406757D0/en not_active Ceased
-
2005
- 2005-03-23 PL PL08157487T patent/PL1958633T3/pl unknown
- 2005-03-23 AT AT08157487T patent/ATE536875T1/de active
- 2005-03-23 PT PT08157487T patent/PT1958633E/pt unknown
- 2005-03-23 BR BRPI0507999-3A patent/BRPI0507999A/pt not_active Application Discontinuation
- 2005-03-23 PT PT05731809T patent/PT1729775E/pt unknown
- 2005-03-23 DK DK05731809T patent/DK1729775T3/da active
- 2005-03-23 PL PL05731809T patent/PL1729775T3/pl unknown
- 2005-03-23 WO PCT/GB2005/001099 patent/WO2005092867A2/en active Application Filing
- 2005-03-23 JP JP2007504474A patent/JP5016478B2/ja not_active Expired - Fee Related
- 2005-03-23 EP EP20080157487 patent/EP1958633B1/en not_active Not-in-force
- 2005-03-23 AT AT05731809T patent/ATE458484T1/de active
- 2005-03-23 DE DE200560019547 patent/DE602005019547D1/de active Active
- 2005-03-23 SI SI200531001T patent/SI1729775T1/sl unknown
- 2005-03-23 ES ES05731809T patent/ES2341658T3/es active Active
- 2005-03-23 CN CN2005800096821A patent/CN101022807B/zh not_active Expired - Fee Related
- 2005-03-23 EP EP20050731809 patent/EP1729775B1/en active Active
- 2005-03-23 AU AU2005225602A patent/AU2005225602A1/en not_active Abandoned
- 2005-03-23 CA CA 2561059 patent/CA2561059C/en not_active Expired - Fee Related
- 2005-03-23 DK DK08157487T patent/DK1958633T3/da active
- 2005-03-23 SI SI200531491T patent/SI1958633T1/sl unknown
- 2005-03-23 RS RSP20100217 patent/RS51306B/sr unknown
- 2005-03-23 US US10/594,380 patent/US8703945B2/en not_active Expired - Fee Related
- 2005-03-23 KR KR20067021900A patent/KR20060130765A/ko not_active Application Discontinuation
- 2005-03-23 ES ES08157487T patent/ES2379481T3/es active Active
-
2006
- 2006-09-25 IL IL178274A patent/IL178274A0/en unknown
-
2010
- 2010-05-21 CY CY101100456T patent/CY1110091T1/el unknown
- 2010-05-21 HR HR20100287T patent/HRP20100287T1/hr unknown
-
2012
- 2012-03-14 CY CY20121100274T patent/CY1115040T1/el unknown
-
2014
- 2014-03-25 US US14/225,018 patent/US9024025B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS51306B (sr) | Postupak i intermedijerna jedinjenja korisna za dobijanje statina, naročito rosuvastatina | |
| TW200643083A (en) | Mercaptosilanes | |
| EP2072582A4 (en) | POLYMERIC COMPOSITION WITH METAL ALKOXIDE CONDENSATION PRODUCT, ORGANIC SILANE COMPOUND AND BORON COMPOUND | |
| ATE497948T1 (de) | Bicyclische verbindungen | |
| ATE328858T1 (de) | Verfahren zur alkoxylierung mit einem bor- enthaltenden katalysator | |
| WO2008078041A3 (fr) | Procede de preparation de composes 1,3,2-oxazaborolidines | |
| IL185884A0 (en) | Method for preparing substittuted pyrimidines | |
| EP1783108A4 (en) | METHOD FOR PRODUCING HALOGEN-SUBSTITUTED BENZENEDIMETHANOL | |
| TW200704632A (en) | Process for the preparation of 1-[cyano(4-hydroxyphenyl)methyl]cyclohexanol compounds | |
| CA2530163A1 (en) | Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin | |
| DK1598358T3 (da) | Forbindelser indeholdende 3,4-methylendioxythiophen-enheder | |
| MY152869A (en) | Chemical process | |
| TW200720282A (en) | Novel organosilicon compound and process for producing the same | |
| AU2003289432A1 (en) | Process for the production of 1-acetoxy-3-(substituted phenyl)propenes | |
| HU0104629D0 (en) | Method for producing cyclopropanecarboxylates | |
| ES2157679T3 (es) | Procedimiento para preparar un compuesto de 2-cianobifenilo. | |
| MXPA05013715A (es) | Proceso para preparar derivados del acido (2s)-3-(4- {2-[amino]-2 -oxoetoxi} fenil)-2- [amino]-2 -oxoetoxi}fenil)-2 -etoxipropanoico. | |
| FR2827595A1 (fr) | Procede de racemisation d'un compose d'acide cyclopropanecarboxylique | |
| EP1726645A4 (en) | PROCESS FOR PREPARING PICOLIC ACID COMPOUNDS | |
| EP1930331A4 (en) | PROCESS FOR PRODUCING IMIDAZO [1,2-b] PYRIDAZINE COMPOUND | |
| EP2028183A4 (en) | NOVEL EPOXY COMPOUND AND PROCESS FOR PRODUCING THE SAME | |
| ATE506349T1 (de) | Verfahren zur herstellung von 7-chinolinyl-3,5- dihydroxyhept-6-enoat | |
| TW200712054A (en) | Method for producing 2,3-dihydropyridazine compound | |
| TWI349003B (sr) | ||
| TW200604141A (en) | Method for producing acetamidopyrrolidine derivative and intermediate compound thereof |